CHICAGO, Feb. 15, 2018 -- Allscripts (NASDAQ:MDRX) has signed a definitive agreement to sell its OneContent business to Hyland Software, Inc., a leading provider of content services solutions to the healthcare industry and beyond. The deal is expected to close in the second quarter once customary closing conditions are satisfied.
Allscripts acquired the OneContent business in late 2017 through the acquisition of McKesson’s EIS portfolio. Upon transaction close, the OneContent client base and associates will transition to Hyland. The two companies will operate independently until the deal closes.
Hyland’s content and image management solutions address the clinical, financial and operational needs of healthcare organizations around the world. We expect that Hyland will continue to support OneContent customers’ current solutions while enhancing the platform with new features and functionality, and refining the integration with Allscripts’ EHR systems.
“Hyland has world-class content and image management solutions, and OneContent is a great fit within their portfolio,” Allscripts President Rick Poulton said. “This deal is a triple win for Allscripts clients and shareholders as it allows us to efficiently recirculate capital; allows us to focus on our core businesses and allows us to maintain our strong, exciting partnership with Hyland.”
Houlihan Lokey acted as the exclusive financial advisor to Allscripts in connection with the sale of OneContent.
About Allscripts
Allscripts (NASDAQ:MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.
© 2018 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.
For more information contact:
Investors:
Dennis Olis
312-386-6700
[email protected]
Media:
Concetta Rasiarmos
312-447-2466
[email protected]


Thomson Reuters C-Track Cyberattack Hits Courts Across U.S. and Canada
Milei Threatens Falkland Oil Firms With Sanctions
SpaceX Turbine Push Unlikely to Threaten Howmet, Bernstein Says
Shein Shares Drop 5% After Weak Hong Kong IPO Debut
MongoDB Stock Sinks 14% as Atlas Growth Misses Expectations
Tesla Cybercab Launch Puts Robotaxi Ambitions in Focus
BP Names Ian Tyler Permanent Chairman After Governance Shake-Up
Tesla Cybercab Rides Launch in Austin as NHTSA Reviews Rollout
Microsoft to Reveal Azure Revenue in Major Reporting Shake-Up
Audi, SAIC Launch China Innovation Hub for New AUDI Models
OpenAI Launches GPT-6 Astra With Advanced AI Agent Capabilities
Nvidia Eyes $2.5 Billion Investment in Thinking Machines Lab
SEC Seeks ISS Client Voting Records in Proxy Adviser Probe
Anthropic IPO Marketing Expected to Start in Mid-October
ByteDance Secures $29.6 Billion Loan to Boost AI Investment
Berkshire Hathaway Eyes Bigger Stakes in Japan’s Top Trading Houses
Fast Retailing Shares Drop as Uniqlo Japan August Sales Fall 



